The BioMerieux ID 32C Yeast Identification System was examined to determine its usefulness as a rapid method for the identification of medically important aerobic actinomycetes. More than 290 strains were tested by this method and the results were compared to those obtained by conventional methods. It was found that aerobic actinomycetes could be differentiated to species level in 7 days by the ID 32C system.
There has been an increase in the occurrence of aerobic actinomycetes in the clinical laboratory in recent years. Infections due to these organisms have become more prevalent with the use of cytotoxic agents, immunosuppression for organ transplants, and the advent of AIDS. Nocardia species have been most often considered as the agents of infection, but laboratories now need to consider members of other genera, such as Rhodococcus, Tsukamurella, and Actinomadura.
The methods currently used in most clinical laboratories for the identification of aerobic actinomycetes are both expensive and slow. The media used are specialized and therefore tend to be available only in the larger laboratories which accept referred isolates. An alternative approach, using thin-layer chromatography or high-performance liquid chromatography, is available for whole-cell analysis of mycolic acids, but these techniques are too complex for the average laboratory. There is a pressing need for a simple, reproducible screening system to identify the more common pathogens in this group. The API ZYM (3), API YeastIdent (8), Microscan Rapid Anaerobe Identification (2) , and Microscan HNID (2) systems have been reported as alternative methods for identification. Since the BioMerieux ID 32C Yeast Identification System is used by many laboratories in Australasia for the identification of yeast isolates, we decided to investigate its potential for the identification of aerobic actinomycetes.
MATERIALS AND METHODS
Procedure. The ID 32C strip consists of 32 cupules, each containing a dehydrated carbohydrate substrate, constituting in effect a miniaturized assimilation system. A semisolid, chemically defined minimal medium is supplied and inoculated with a suspension of the organism to be tested. The analytical profile index for the ID 32C system is based on an eight-digit profile determined with the substrates sorbitol, D-xylose, ribose, glycerol, rhamnose, palatinose, erythritol, melibiose, glucuronate, melezitose, gluconate, levulinate, galactose, actidione, sucrose, N-acetylglucosamine, DL-lactate, L-arabinose, cellobiose, raffinose, maltose, trehalose, 2-ketogluconate, and ␣-methyl-D-glucoside. Additional tests to be used in cases of low discrimination, i.e., when indicated by the analytical profile index, are sorbose, glucosamine, esculin, mannitol, lactose, and inositol. Glucose is included as a positive control, and a blank well is included as a negative control.
Test isolates were grown on nutrient or brain heart infusion agar at 35°C. A McFarland no. 4 suspension was prepared in sterile physiological saline. One ml of this suspension was inoculated into ID 32C medium, and 3 drops were dispensed into each well of the strip. The strips were incubated for 7 days at 35°C in a sealed container to prevent evaporation. The strips were read to give an eight-digit profile, as detailed in the instruction leaflet. Slide cultures were also prepared on brain heart infusion agar and incubated at 35°C for 2 to 3 days and then stained with lactophenol cotton blue for microscopic details.
Isolates were also identified by standard procedures (1, 6) The majority of strains (59%) were clinical isolates referred to the Australian National Reference Laboratory in Medical Mycology (AMMRL) for identification. Of these isolates, 76% were Nocardia spp., 18% were Streptomyces spp., and 6% were Rhodococcus spp. Nocardia species represented 57% of respiratory isolates (30% were N. asteroides and 6% were N. farcinica), 27% of skin abscess or tissue isolates (9% were N. brasiliensis), and 5% of wound swab isolates. Of the remaining isolates, Streptomyces griseus was the most common, representing 9% of isolates, with 5% of these being of respiratory origin.
Isolates maintained by the culture collection of this laboratory were also used. These have the AMMRL acronym in the accompanying tables and had been maintained on agar or in sterile saline as part of the culture collection. Culture collection strains used in this study comprised 41% of those tested, including strains obtained from T. Donev, National Bank of Industrial Microorganisms 
RESULTS
After testing 293 isolates, we found that the method described here can identify and differentiate between N. asteroides, N. brasiliensis, N. otitidiscaviarum, N. farcinica, Nocardiopsis dassonvillei, Streptomyces species, Rhodococcus species, and other aerobic actinomycetes.
Interpretation of the growth in the ID 32C wells is not difficult for most isolates. Partial or weak growth may result in an alternative profile, which would explain some of the additional profiles in Table 2 . This table also sets out the profiles obtained by the ID 32C system. Only those isolates which could be identified by conventional methods have been included.
Using an eight-digit profile as used for yeasts, we observed that the last four digits showed consistent correlation between isolates within a species and enabled species to be distinguished from one another ( Table 3 ). The first four digits showed poor correlation within a species and between species. Table 4 is an outline of the relationship between species and profiles. There were two predominant profiles obtained for N. asteroides. If a difference in reading of one sugar is allowed, 64% of isolates conform to these profiles. There was only one predominant profile for N. brasiliensis. If a difference in reading of one sugar is allowed, 90% of isolates conform. N. farcinica also had one predominant profile, to which 38% of profiles conform. Sensitivity studies were only preliminary at the time of the present study and may be necessary for a full identification of this species. R. rhodochrous again had one predominant profile, to which 100% of profiles conform with a difference in reading of one sugar. Numbers of isolates in the other species were too small to allow this type of analysis. Table 1 gives the profiles recorded for the control strains used in this study.
DISCUSSION
As expected, there is a large variability within the isolates of the N. asteroides complex. In recent years, several new or resurrected species have been separated from the N. asteroides complex. N. farcinica is more resistant to antibiotics than N. asteroides, and this has important clinical implications. Carson and Hellyar (4) and Flores and Desmond (5) reported that opacification of Middlebrook agar and sensitivity testing could differentiate these two species. N. nova has also been differentiated from N. asteroides by DNA analysis (10) and antimicrobial resistance pattern (9) and, like N. farcinica, needs to be distinguished from N. asteroides in the laboratory so that the correct therapy can be given. There is still a large variability present in the N. asteroides group, which future investigators may unravel.
Preparation of even suspensions of the isolates can pose some problems. The Nocardia and Rhodococcus isolates present little difficulty, and other isolates can be dispersed with a sonicator. Many of the more glabrous colonies of Actinomadura, Nocardiopsis, and some of the Streptomyces species are difficult to break up. A sonicator may be used, but grinding the colony in a mortar and pestle is often the only solution.
The Streptomyces species are difficult to identify by the meth- A. madurae and A. pelletieri are the only medically significant Actinomadura species and can be separated on the basis of esculin hydrolysis. This is the last test on the ID 32C strip. The profiles obtained in the present study also differ sufficiently for identification of the two species, although our sample size was small.
Rhodococcus is a heterogeneous group of microorganisms. R. equi appears to be the most clinically significant species in man and animals. This is readily identified by the ID 32C system. Insufficient data for the other species is available to estimate the usefulness of the ID 32C system in their identification. Tables 2 and 3 show that there is sufficient difference in the profiles of the medically significant species of aerobic actinomycetes tested to have confidence in their accurate identification. Repeated testing of a number of these isolates resulted in profiles identical to those originally obtained or profiles varying by one or two tests, consistent with the analysis shown in Table 3 .
While developing this system for identifying aerobic actinomycetes, we found that there was very little discrepancy between the identifications produced by the ID 32C system and those obtained by conventional methods. Prior to the present study, 2 isolates of N. carnea, 1 isolate of N. transvalensis, 4 isolates of N. farcinica and 10 isolates of N. nova had been identified as part of the N. asteroides complex. Subsequent testing by conventional methods, together with sensitivity tests, confirmed the identifications obtained by the ID 32C system.
We found that one of our clinical isolates was identified as N. asteroides by conventional methods but gave no profile by the ID 32C system on repeated testing. One isolate identified as S. griseus by the ID 32C system could not be identified to the species level by conventional methods.
We also found that one of the isolates of A. pelletieri from our culture collection produced a profile which was more consistent with those given by strains of A. madurae.
The enzymatic systems of identification reported by Boiron and Proveste (3), Biehle et al. (2) , and Richter et al. (8) , are much faster to perform than the method described in this work. Richter et al. (8) investigated the API YeastIdent system as a means of subtyping known N. asteroides isolates in order to estimate their virulence, rather than using the system for the identification of aerobic actinomycetes. Boiron and Proveste (3) tested known strains of N. asteroides only and did not test other Nocardia species. They found that, with 14 isolates, they could obtain consistent results by the API ZYM system. We have investigated the use of the API ZYM system and have found that it does not always give consistent results within a species. Identification of the species of Nocardia is based on the activity of only one or two enzymes, and there is a greater potential for error than with the present method. Biehle et al. (2) also found that of the enzymes available to them, only three were useful for the differentiation of Nocardia species. They did not, however, discern the difference between the reactions of Nocardia species and other aerobic actinomycetes, which may give the same reactions to these enzymes. None of the above-mentioned authors investigated the use of their reported methods for differentiating the pathogenic species of aerobic actinomycetes encountered in the clinical laboratory. By testing a large number of isolates, the present study has shown that the ID 32C system can be used to give reliable identification of many of the aerobic actinomycetes encountered in these laboratories. The relative speed of identification compared with traditional methods suggests that the method outlined here would be attractive to laboratories contemplating the identification of aerobic actinomycetes, especially those laboratories that are already using the ID 32C system for the identification of yeasts.
